SHMT2 and bladder transitional cell carcinoma: To investigate the metabolic mechanism of SHMT2 in BLCA, we conducted GO enrichment analysis using transcriptome sequencing of BLCA clinical samples and two sets of data from the TCGA database (Fig. 3).